New View Surgical, Inc. Closes $12.1M Series B-1 Financing and Prepares for Limited Commercialization of its VisionPort™ System for Minimally Invasive Surgery

November 21, 2022

BOSTON-(BUSINESS WIRE)–New Surgical View, Inc., an emerging medical device company developing proprietary imaging and access technologies for minimally invasive surgery (MIS), today announced the closing of a Series B equity financing round- 1 of $12.1 million to finance the commercialization of its VisionPort™ system. The company plans to launch the VisionPort system in the United States before the end of 2022.

The VisionPort™ System is a new surgical imaging and access system that simplifies laparoscopic procedures by reducing the need for a separate camera port and camera stand, thereby reducing the need for a member of the separate surgical team to hold and manage a laparoscope. In emerging markets, the VisionPort™ system will significantly reduce the capital-intensive equipment currently required to perform minimally invasive surgery and, therefore, make advanced technology more accessible. The VisionPort system is intended for use in a wide range of diagnostic and therapeutic procedures in the thoracic and abdominal cavities and is adaptable to a wide variety of surgical environments, representing a significant market opportunity.

“We are excited to bring this breakthrough technology to leading hospitals and surgical teams that supports our mission to advance the growth of minimally invasive surgical procedures worldwide, holistically addressing the clinical, operational and financial needs of the operating room,” Bryce Klontz said. , Chairman and CEO. “Funds raised in this Series B-1 come exclusively from our current investors, which is a testament to our company’s accomplishments to date and our vision for how we can positively impact the surgery space. minimally invasive in the future. »

New View Surgical’s Commercial Director, Shane Johnson, said, “I’ve been blessed to be involved with incredible technology during my career. This is the first time I have launched a product that adds value to all stakeholders, clinical and financial, in such a profound way. The VisionPort system is unique in that it provides surgeons with new views of the operating field, workflow efficiencies for staff, reduced risks for the patient, and reduced costs for the facility.

“The message from surgeons who have used the VisionPort couldn’t be clearer: the device simplifies and improves the operator’s view of the surgical field,” said Dr. John Younger, member of the New View Surgical Board and one partners of the agreement. leads for the New York Angels. “Beyond that, I think what drove the investors to close the deal was this: the instrument’s ability to eliminate the need for a separate team member to manage a conventional laparoscope and the VisionPort’s ability to reduce recurring capital and equipment costs makes the value proposition extremely economical for surgical practices.”

About New View Surgical, Inc.
New View Surgical is an emerging medical device company focused on the development and commercialization of the VisionPort™ system, a novel surgical imaging and access system for minimally invasive surgery. The company is led by an experienced team of medical device innovators and business experts who have come together to design and bring to market impactful solutions that address a variety of unmet market needs. The company’s proprietary VisionPort™ system combines multiple imaging and access devices into one simple, easy-to-use device that is disposable and expected to bring a variety of clinical, operational and financial benefits to surgical operating rooms minimally invasive around the world. For more information, please visit


For press inquiries:
New Surgical View, Inc.
[email protected]

Christine E. Phillips